Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
August 1, 2025Open Access

Toward Smarter Drug Delivery Solutions via Liposomal Carriers, Effervescent Formulations, and Extracellular Vesicles

View Full Paper
Ask AI
Bookmark
Share

Authors

ASAshutosh Sengar

Discussion

Loading...

Member takes

Overview

This review demonstrates improved bioavailability and targeting in drug delivery systems using liposomal and extracellular vesicles, suggesting new clinical applications.

Key Points

  • Smart drug delivery systems enhance medical efficacy while reducing side effects for better patient outcomes.
  • Liposomal technologies and nanotechnology improve bioavailability and allow for targeted therapy in hard-to-reach areas.
  • Innovations like extracellular vesicles mimic natural transport systems, offering advancements in clinical applications.
  • Safety and scalability remain crucial for regulatory acceptance of these advanced drug delivery platforms.

Cite This Study

Ashutosh Sengar (2025) studied this question.

synapsesocial.com/papers/689a0c65e6551bb0af8cfbd2https://doi.org/10.20944/preprints202507.2595.v1
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Comprehensive Developments in Targeted Drug Delivery Using Liposomes Nanoparticles and Vesicular Systems2025 · 1 citations
  2. 2Advancements in Targeted Drug Delivery: Innovations in Liposomal, Nanoparticle, and Vesicular Systems2025
  3. 3Advances in Drug Delivery Systems2024 · 24 citations
  4. 4Nanotechnology-driven smart drug delivery systems bridging pharmaceutical sciences biomaterials and clinical translation2026
  5. 5Nanotechnology-Driven Drug Delivery System: Recent Advances, Applications and Future Perspectives2026